Published online Jun 16, 2022. doi: 10.12998/wjcc.v10.i17.5756
Peer-review started: November 9, 2021
First decision: December 27, 2021
Revised: January 4, 2022
Accepted: April 9, 2022
Article in press: April 9, 2022
Published online: June 16, 2022
Processing time: 212 Days and 7 Hours
We report a rare case of a large congenital hemangioma (CH) in the maxillofacial region in a female neonate that caused thrombocytopenia and heart failure. With close multidisciplinary collaboration, the congenital hemangioma was succ
The patient was delivered at gestational age of 36 wk by cesarean section due to cephalopelvic disproportion and lack of onset of labor (birth weight: 2630 g). A right-sided facial tumor was detected in the fetus during routine antenatal ultrasound examination of the mother at 32 wk of gestation. Physical examination revealed a 7 cm × 7 cm × 3 cm hard, dull purple-colored mass on the right maxillofacial region. The mass was tense and had prominent surface telangiectasias. Laboratory investigations revealed reduced hemoglobin and platelet count, and increased activated partial thromboplastin time, prothrombin time, and thrombin time. International normalized ratio, fibrin degradation products, and D-Dimer levels were significantly increased. Thromboelastography showed increased alpha angle, mean amplitude, and the clot formation speed. Thyroid-stimulating hormone level was significantly elevated. The patient was administered prednisone, propranolol, euthyrox, vitamin K1, milrinone, and digoxin. After operation, cefepime was administered for anti-infection and propranolol was prescribed at discharge.
We report a rare case of CH in the right maxillofacial region causing thrombocytopenia and heart failure.
Core Tip: The present report highlights the management strategy for congenital hemangiomas, i.e., protection of hemangioma before surgical resection, appropriate use of propranolol to contain the size and tension of the hemangioma, correction of anemia and thrombocytopenia, and improvement of congestive heart failure. Multidisciplinary collaboration is vital to achieve good outcomes.
